These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15459407)

  • 21. A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea.
    Barbee LA; Kerani RP; Dombrowski JC; Soge OO; Golden MR
    Clin Infect Dis; 2013 Jun; 56(11):1539-45. PubMed ID: 23408680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique.
    Apalata T; Zimba TF; Sturm WA; Moodley P
    Sex Transm Dis; 2009 Jun; 36(6):341-3. PubMed ID: 19556927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of lichen sclerosus with antibiotics.
    Shelley WB; Shelley ED; Amurao CV
    Int J Dermatol; 2006 Sep; 45(9):1104-6. PubMed ID: 16961523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended surveillance of gonorrhoea in Scotland 2003.
    Young H; McElhinney J; Palmer HM;
    Int J STD AIDS; 2006 Oct; 17(10):687-92. PubMed ID: 17059639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral cephalosporins: newer agents and their place in therapy.
    Thompson EM; Shaughnessy AF
    Am Fam Physician; 1994 Aug; 50(2):401-5. PubMed ID: 8042575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.
    Martin IM; Hoffmann S; Ison CA;
    J Antimicrob Chemother; 2006 Sep; 58(3):587-93. PubMed ID: 16816397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
    van Amerongen R; Gazendam RP; van Bergen JEAM
    BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience in the use of cefuroxime in gonorrhoea.
    Fowler W; Rahim G; Brown JD
    Br J Vener Dis; 1978 Dec; 54(6):400-2. PubMed ID: 737517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic prophylaxis in cardiothoracic surgery 1990: results of a third survey.
    Woods M; Tillman D
    Hosp Pharm; 1992 May; 27(5):404, 406-7. PubMed ID: 10170986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
    Sutrisna A; Soebjakto O; Wignall FS; Kaul S; Limnios EA; Ray S; Nguyen NL; Tapsall JW
    Int J STD AIDS; 2006 Dec; 17(12):810-2. PubMed ID: 17212856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.
    Coenen S; Ferech M; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):413-7. PubMed ID: 16735416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and treatment of gonorrhea in Copenhagen and Frederiksberg].
    Wildt S; Danielsen AG; Friis-Møller A
    Ugeskr Laeger; 2003 Oct; 165(44):4224-7. PubMed ID: 14621556
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of cefuroxime for the treatment of acute gonorrhoea in men.
    Price JD; Fluker JL
    Br J Vener Dis; 1978 Jun; 54(3):165-7. PubMed ID: 656890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
    Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
    J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
    De Jongh M; Dangor Y; Adam A; Hoosen AA
    Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.